Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Extramembranous glomerulopathies].

D Glotz1, J Bariéty, P Druet

  • 1INSERM U28 et service de néphrologie, hôpital Broussais, Paris.

La Revue Du Praticien
|November 15, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Renal transplantation outcomes in obese patients: a French cohort-based study.

BMC nephrology·2021
Same author

Utility of anaerobic bottles for the diagnosis of bloodstream infections.

BMC infectious diseases·2020
Same author

Intravenous Immunoglobulins in the Prevention of Rejection of a Second or Third Kidney Graft.

Transplantation proceedings·2018
Same author

The Banff 2017 Kidney Meeting Report: Revised diagnostic criteria for chronic active T cell-mediated rejection, antibody-mediated rejection, and prospects for integrative endpoints for next-generation clinical trials.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2017
Same author

Harnessing Scientific and Technological Advances to Improve Equity in Kidney Allocation Policies.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2017
Same author

The Banff 2015 Kidney Meeting Report: Current Challenges in Rejection Classification and Prospects for Adopting Molecular Pathology.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2016
Same journal

[Prolonged fever].

La Revue du praticien·2026
Same journal

[Lower gastrointestinal bleeding].

La Revue du praticien·2026
Same journal

[Management of antiplatelet agents and oral anticoagulants in cases of gastrointestinal bleeding].

La Revue du praticien·2026
Same journal

[A history of child abuse intervention in the West].

La Revue du praticien·2026
Same journal

[Agranulocytose médicamenteuse].

La Revue du praticien·2026
Same journal

[Patient education in heart failure].

La Revue du praticien·2026
See all related articles

Membranous nephropathy involves immune deposits on the glomerular basal membrane, often presenting as nephrotic syndrome. Current treatments have not definitively altered the disease

Area of Science:

  • Nephrology
  • Immunology
  • Pathology

Background:

  • Membranous nephropathy is characterized by immune deposits on the epithelial side of the glomerular basal membrane.
  • The pathogenesis is linked to in situ immune complex formation.
  • Clinically, it often manifests as nephrotic syndrome with variable long-term outcomes.

Purpose of the Study:

  • To review the current understanding of membranous nephropathy.
  • To discuss the natural history and available treatment strategies.
  • To highlight the lack of prognostic criteria and treatment efficacy.

Main Methods:

  • Literature review of experimental models and clinical studies.
  • Analysis of disease mechanisms and clinical presentation.
  • Evaluation of treatment outcomes for steroids and immunosuppressive agents.

Related Experiment Videos

Main Results:

  • The disease mechanism involves in situ immune complex formation.
  • Natural history shows spontaneous remission in 25% and progressive renal failure in 20% of patients.
  • No clear prognostic criteria are currently available.
  • Existing treatment protocols using steroids or immunosuppressants have not demonstrably altered the disease course.

Conclusions:

  • Membranous nephropathy remains a condition with unpredictable outcomes.
  • Further research is needed to identify prognostic markers and effective therapies.
  • Current treatment strategies lack proven efficacy in modifying the long-term prognosis.